Please try another search
Mainz Biomed N.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics. It offers ColoAlert, a colorectal cancer screening stool-based deoxyribonucleic acid test; and PancAlert, a product candidate for a pancreatic cancer screening test. The company has a research collaboration with Microba Life Sciences to discover and develop novel therapeutics for major diseases. The company was founded in 2008 and is based in Mainz, Germany.
Name | Age | Since | Title |
---|---|---|---|
Soren Thestrup-Nielsen | - | 2021 | Member of Strategic Advisory Board |
Rainer Metzger | - | 2022 | Member of Strategic Advisory Board |
D. Kim Turgeon | - | 2022 | Member of Medical Advisory Board |
Michele Pedrocchi | - | 2022 | Member of Strategic Advisory Board |
Douglas K. Rex | - | 2022 | Member of Medical Advisory Board |
Timothy Cragin Wang | - | 2022 | Member of Medical Advisory Board |
Alberto Libanori | 33 | 2021 | Independent Non-Executive Director |
Hans Johan Hekland | 65 | 2021 | Independent Non-Executive Director |
Nicole Holden | 49 | 2021 | Independent Non-Executive Director |
Heinrich Dreismann | 70 | 2021 | Independent Non-Executive Chairman |
Gregory J. Tibbitts | 56 | 2022 | Independent Non-Executive Director |
Nicole Holden | 50 | 2021 | Independent Non-Executive Director |
Guido Baechler | 59 | 2021 | CEO & Executive Director |
Moritz Eidens | 40 | 2008 | Chief Science Officer & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review